Insulin attenuates the stimulatory effects of tumor necrosis factor α on 11β-hydroxysteroid dehydrogenase 1 in human adipose stromal cells

被引:38
|
作者
Handoko, K
Yang, KP
Strutt, B
Khalil, W
Killinger, D [1 ]
机构
[1] Univ Western Ontario, Dept Pharmacol & Toxicol, Lawson Res Inst, St Josephs Hlth Ctr, London, ON N6A 4V2, Canada
[2] Univ Western Ontario, St Josephs Hlth Ctr, Dept Physiol, Lawson Res Inst, London, ON N6A 4V2, Canada
[3] Univ Western Ontario, St Josephs Hlth Ctr, Dept Obstet & Gynecol, Lawson Res Inst, London, ON N6A 4V2, Canada
[4] Univ Western Ontario, St Josephs Hlth Ctr, Dept Med, Lawson Res Inst, London, ON N6A 4V2, Canada
[5] Univ Utrecht, Dept Pharmacol, NL-3584 CA Utrecht, Netherlands
基金
英国医学研究理事会;
关键词
glucocorticoids; type; 2; diabetes; insulin-resistance;
D O I
10.1016/S0960-0760(00)00029-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity is frequently associated with insulin-resistance and abnormal glucose homeostasis. Recent evidence indicates that TNF alpha may play a role in mediating the insulin-resistance of obesity through its overexpression in adipose tissue. Previously, we have shown that human adipose stromal cells contain 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) mRNA and activity. The present study was designed to examine the effects of insulin on 11 beta-HSD1 expression in human adipose stromal cells under basal and TNF alpha-stimulated conditions. The cells were obtained from breast adipose tissue by collagenase digestion, and grown to confluence under replicating conditions in 10% fetal bovine serum. The cells were transferred to serum-free medium for 24 h prior to treatment with either TNF alpha, insulin or both for a further 24 h. The level of 11 beta-HSD1 reductase activity was determined by measuring the conversion of [H-3]-cortisone to [H-3]-cortisol at a substrate concentration of 10 nM, Treatment with TNF alpha at concentrations of 0.1-10 ng/ml resulted in a dose dependent increase in 11 beta-HSD1 reductase activity from 1.5 to 10-fold. Insulin (0.1-100 nM) had no effect under basal conditions, but inhibited the stimulatory effects of TNF alpha (5 ng/ml) on 11 beta-HSD1 reductase activity in a dose dependent fashion (8-66%) inhibition. Northern blot analysis revealed corresponding changes in the level of 11 beta-HSD1 mRNA, suggesting that the effects of TNF alpha and insulin on 11 beta-HSD1 activity are mediated at the level of gene transcription. The interaction between insulin and TNF alpha suggests that local and systemic factors may act in a concerted fashion to modulate glucocorticoid activity in adipose and other peripheral tissues. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 50 条
  • [1] Oxysterols attenuate the stimulatory effects of TNFα on 11 hydroxysteroid dehydrogenase type 1 (11βHSD1) activity in human adipose stromal cells
    Khalil, W
    Lee, K
    Lim, H
    Smith, N
    Richards, R
    Yang, K
    Killinger, D
    [J]. PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 515 - 521
  • [2] Differentiation of adipose stromal cells:: The roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase
    Bujalska, IJ
    Kumar, S
    Hewison, M
    Stewart, PM
    [J]. ENDOCRINOLOGY, 1999, 140 (07) : 3188 - 3196
  • [3] A study on 11β-hydroxysteroid dehydrogenase type 1 in primary culture of rat adipose stromal cells
    Hong, GH
    Kim, DH
    Choi, SH
    Chun, BG
    [J]. FASEB JOURNAL, 2004, 18 (05): : A993 - A993
  • [4] A switch in dehydrogenase to reductase activity of 11,6-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells
    Bujalska, IJ
    Walker, EA
    Hewison, M
    Stewart, PM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03): : 1205 - 1210
  • [5] 11 beta-Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: Effect on aromatase activity
    Yang, K
    Khalil, MW
    Strutt, BJ
    Killinger, DW
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 60 (3-4): : 247 - 253
  • [6] 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells
    Lee, Sang Eun
    Lee, Eun Young
    Kang, Sang Jin
    Lee, Seung Hun
    [J]. YONSEI MEDICAL JOURNAL, 2017, 58 (06) : 1204 - 1210
  • [7] 11β-hydroxysteroid dehydrogenase type 1 inhibition attenuates the adverse effects of glucocorticoids on dermal papilla cells
    Choi, J.
    Lee, S.
    Lee, E.
    Kang, S.
    Lee, S.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S237 - S237
  • [8] Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity
    Tomlinson, JW
    Sinha, B
    Bujalska, I
    Hewison, M
    Stewart, PM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (12): : 5630 - 5635
  • [9] Expression of 11 beta-hydroxysteroid dehydrogenase during decidualization of human endometrial stromal cells
    Arcuri, F
    Monder, C
    Lockwood, CJ
    Schatz, F
    [J]. ENDOCRINOLOGY, 1996, 137 (02) : 595 - 600
  • [10] 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance
    Koska, Juraj
    de Courten, Barbora
    Wake, Deborah J.
    Nair, Saraswathy
    Walker, Brian R.
    Bunt, Joy C.
    Permana, Paska A.
    Lindsay, Robert S.
    Tataranni, P. Antonio
    [J]. OBESITY, 2006, 14 (09): : 1515 - 1522